Myopia Control: What It Can and Can’t Do (Realistic Expectations)
Understanding Myopia Control
If your child has been diagnosed with myopia (nearsightedness), you may be wondering whether myopia control treatments can truly make a difference. Myopia control has become one of the most important advances in pediatric eye care, but understanding what these treatments can realistically achieve is just as important as knowing they exist. At Greenwich Ophthalmology Associates, our myopia management specialists help families across the greater NY/CT region set informed, practical expectations so they can make confident decisions about their child's long-term eye health.
A 2021 analysis published in Ophthalmology by the American Academy of Ophthalmology found that each additional diopter of myopia is associated with a 58 percent increase in the risk of myopic maculopathy and a 30 percent increase in the risk of retinal detachment, which means that even slowing progression by one diopter can meaningfully reduce long-term risk (Bullimore and Brennan, Ophthalmology, 2021).
What Myopia Control Means
Myopia control refers to a range of treatments designed to slow the progression of nearsightedness in children, rather than simply correcting blurry distance vision with standard glasses or contact lenses. The goal of myopia control is not to reverse or eliminate myopia. Instead, these treatments aim to reduce how quickly a child's prescription increases over time. A child whose myopia progresses more slowly is less likely to develop high myopia, which is associated with a greater risk of serious eye conditions later in life, including retinal detachment, myopic macular degeneration, and glaucoma.
Myopia occurs when the eye grows too long from front to back, causing light to focus in front of the retina rather than on it. This measurement, called axial length, is the key indicator that myopia control treatments target. Reducing the rate of axial elongation is the primary way these treatments protect long-term vision health, even if your child still needs glasses or contacts for clear distance sight.
For decades, nearsightedness was managed by prescribing stronger lenses each year as a child's vision changed. Today, we understand that simply correcting blurry vision does not address the underlying issue of progressive eye growth. Myopia control represents a proactive approach that focuses on reducing future risk rather than waiting for problems to develop.
How Myopia Control Works
Several evidence-based treatment options are available for slowing myopia progression. Low-dose atropine drops are applied once daily, typically at bedtime. Atropine is a medication that, in very low concentrations (often 0.01% to 0.05%), has been shown in clinical studies to slow myopia progression by roughly 30 to 50 percent in many children. The exact mechanism is still being studied, but it appears to act on receptors in the eye that influence growth signaling.
Orthokeratology involves wearing specially designed rigid gas-permeable contact lenses overnight. These lenses gently reshape the front surface of the cornea while your child sleeps, providing clear vision during the day without glasses or daytime contacts. Research consistently shows that Ortho-K can reduce myopia progression by approximately 40 to 60 percent compared to standard glasses.
Newer spectacle lens designs, such as defocus incorporated multiple segments (DIMS) and highly aspherical lenslet (HAL) technology, have demonstrated the ability to slow myopia progression in children. These lenses look and feel similar to regular glasses but incorporate optical zones that create a specific type of defocus shown to reduce eye growth. Certain soft multifocal contact lenses designed for myopia control create peripheral defocus patterns on the retina that help slow axial elongation.
Spending more time outdoors, particularly during daylight hours, has been linked to a lower risk of developing myopia and may help slow its progression. While outdoor time alone is not a standalone treatment for established myopia, it serves as an important complementary strategy alongside clinical interventions.
Who Benefits Most from Myopia Control
Myopia control is most effective when started early in childhood, ideally during the years when the eyes are growing most rapidly. Children between the ages of 6 and 12 tend to experience the fastest rates of myopia progression. Starting treatment during this window offers the greatest opportunity to slow eye growth before the prescription climbs into higher ranges. Even children diagnosed at a slightly older age can still benefit, though earlier intervention generally produces better long-term outcomes.
A child whose prescription is increasing by 0.50 diopters or more per year is considered a fast progressor and stands to gain the most from myopia control. Monitoring axial length over time helps our team identify rapid progression, sometimes before a noticeable change in glasses prescription occurs.
Children with one or both parents who are significantly nearsighted face a higher risk of developing high myopia themselves. For these families, myopia control can be an especially valuable way to reduce the likelihood that a child's prescription reaches levels associated with greater long-term risk.
What Myopia Control Can and Cannot Do
Setting realistic expectations is one of the most important parts of the myopia control conversation. Myopia control treatments can meaningfully slow the rate at which your child's nearsightedness worsens. Clinical studies show that current treatments reduce progression by approximately 30 to 60 percent on average, depending on the method used and the individual child. Over several years, this reduction can translate into a significantly lower final prescription, which lowers the lifetime risk of complications such as retinal detachment and myopic macular degeneration.
Myopia control cannot stop myopia progression entirely in most children, and it cannot reverse nearsightedness that has already developed. Your child will still need glasses or contact lenses for clear distance vision during and after treatment. No current treatment brings the rate of progression to zero for every patient, and some children respond more strongly to treatment than others.
Every child responds differently to myopia control. Some children experience a dramatic slowing of progression, while others see a more modest effect. Factors that influence response include the child's age at treatment onset, their baseline rate of progression, genetics, and how consistently the treatment is used. If one approach is not producing the desired results, our team may recommend adjusting the strategy or combining treatments for a stronger effect.
Even a moderate reduction in myopia progression can have a meaningful impact on your child's eye health decades from now. Research suggests that every diopter of myopia prevented reduces the risk of myopic macular degeneration by roughly 40 percent. Myopia control is best understood as a long-term investment in your child's vision, not a quick fix.
Frequently Asked Questions
Side effects vary by treatment type. Low-dose atropine may cause mild light sensitivity or slight difficulty with near-focus tasks in some children, though these effects are generally minimal at lower concentrations. Ortho-K and contact lens treatments carry a small risk of eye infection if lenses are not properly cleaned and handled.
The initial visit typically includes a comprehensive eye exam, a measurement of your child's axial length, and a detailed discussion of your child's vision history and risk factors. We use this information to recommend a personalized treatment plan. Most families leave the first visit with a clear understanding of which treatment options are most appropriate.
Most children continue myopia control treatment throughout their growing years, often until their mid-to-late teens when eye growth naturally slows. Stopping treatment too early can lead to a rebound effect, where progression temporarily accelerates. We monitor your child's axial length and prescription changes over time to guide decisions about when to taper or discontinue treatment.
Myopia control does not eliminate the need for vision correction. Your child will still require glasses or contact lenses for clear distance vision. The goal is to keep the final prescription as low as possible to reduce the risk of complications associated with higher levels of myopia. Orthokeratology does offer the benefit of clear daytime vision without glasses, but it achieves this through temporary corneal reshaping rather than a permanent correction.
The cost of myopia control varies depending on the treatment chosen. Atropine drops are generally the least expensive option, while Ortho-K and specialty contact lenses tend to involve higher upfront fitting fees and ongoing lens replacement costs. Many families find that the long-term health benefits justify the investment.
Delaying treatment allows myopia to progress unchecked during the critical years of rapid eye growth. Each additional diopter of myopia increases the risk of sight-threatening complications later in life. While myopia control can still be beneficial when started at an older age, earlier intervention consistently produces better outcomes in clinical studies.
What our Patients say
4.8
Reviews
(3,408)